These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1520877

  • 1. Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: the addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells.
    Maloney DG, Brown S, Czerwinski DK, Liles TM, Hart SM, Miller RA, Levy R.
    Blood; 1992 Sep 15; 80(6):1502-10. PubMed ID: 1520877
    [Abstract] [Full Text] [Related]

  • 2. Anti-idiotype antibodies can induce long-term complete remissions in non-Hodgkin's lymphoma without eradicating the malignant clone.
    Davis TA, Maloney DG, Czerwinski DK, Liles TM, Levy R.
    Blood; 1998 Aug 15; 92(4):1184-90. PubMed ID: 9694706
    [Abstract] [Full Text] [Related]

  • 3. Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon.
    Brown SL, Miller RA, Horning SJ, Czerwinski D, Hart SM, McElderry R, Basham T, Warnke RA, Merigan TC, Levy R.
    Blood; 1989 Feb 15; 73(3):651-61. PubMed ID: 2465039
    [Abstract] [Full Text] [Related]

  • 4. A clinical trial of anti-idiotype therapy for B cell malignancy.
    Meeker TC, Lowder J, Maloney DG, Miller RA, Thielemans K, Warnke R, Levy R.
    Blood; 1985 Jun 15; 65(6):1349-63. PubMed ID: 3888313
    [Abstract] [Full Text] [Related]

  • 5. Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma.
    Navarrete MA, Heining-Mikesch K, Schüler F, Bertinetti-Lapatki C, Ihorst G, Keppler-Hafkemeyer A, Dölken G, Veelken H.
    Blood; 2011 Feb 03; 117(5):1483-91. PubMed ID: 21045197
    [Abstract] [Full Text] [Related]

  • 6. Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial.
    Hsu FJ, Caspar CB, Czerwinski D, Kwak LW, Liles TM, Syrengelas A, Taidi-Laskowski B, Levy R.
    Blood; 1997 May 01; 89(9):3129-35. PubMed ID: 9129015
    [Abstract] [Full Text] [Related]

  • 7. Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors.
    Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R.
    N Engl J Med; 1992 Oct 22; 327(17):1209-15. PubMed ID: 1406793
    [Abstract] [Full Text] [Related]

  • 8. Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphoma.
    Basham TY, Kaminski MS, Kitamura K, Levy R, Merigan TC.
    J Immunol; 1986 Nov 01; 137(9):3019-24. PubMed ID: 3760580
    [Abstract] [Full Text] [Related]

  • 9. Anti-idiotypes in B-cell tumor therapy.
    Miller RA, Lowder J, Meeker TC, Brown S, Levy R.
    NCI Monogr; 1987 Nov 01; (3):131-4. PubMed ID: 3493440
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype.
    Raffeld M, Neckers L, Longo DL, Cossman J.
    N Engl J Med; 1985 Jun 27; 312(26):1653-8. PubMed ID: 3923351
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synergistic antitumor activity with IFN and monoclonal anti-idiotype for murine B cell lymphoma. Mechanism of action.
    Basham TY, Race ER, Campbell MJ, Reid TR, Levy R, Merigan TC.
    J Immunol; 1988 Oct 15; 141(8):2855-60. PubMed ID: 2971732
    [Abstract] [Full Text] [Related]

  • 15. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
    Giardina SL, Schroff RW, Kipps TJ, Woodhouse CS, Abrams PG, Rager HC, Morgan AC, Foon KA.
    J Immunol; 1985 Jul 15; 135(1):653-8. PubMed ID: 3873497
    [Abstract] [Full Text] [Related]

  • 16. Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma.
    Davis TA, Hsu FJ, Caspar CB, van Beckhoven A, Czerwinsk DK, Liles TM, Taidi B, Benike CJ, Engleman EG, Levy R.
    Biol Blood Marrow Transplant; 2001 Jul 15; 7(9):517-22. PubMed ID: 11669219
    [Abstract] [Full Text] [Related]

  • 17. Treatment of two patients with B cell lymphoma with monoclonal anti-idiotype antibodies.
    Rankin EM, Hekman A, Somers R, ten Bokkel Huinink W.
    Blood; 1985 Jun 15; 65(6):1373-81. PubMed ID: 3873264
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro.
    Maloney DG, Kaminski MS, Burowski D, Haimovich J, Levy R.
    Hybridoma; 1985 Jun 15; 4(3):191-209. PubMed ID: 3899906
    [Abstract] [Full Text] [Related]

  • 19. Idiotype vaccination post-bone marrow transplantation for B-cell lymphoma: initial studies in a murine model.
    Kwak LW, Campbell M, Levy R.
    Cancer Detect Prev; 1991 Jun 15; 15(4):323-5. PubMed ID: 1794139
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.